The COVID-19 pandemic has created numerous challenges in healthcare, but challenges can sometimes breed innovation. Technological innovation in particular is poised to change the way care is delivered, driving efficiency in the process. Efficiency will…
The U.S. may have entered into a new phase of the COVID-19 pandemic, but the public health crisis is far from over and the nation’s hospitals and health systems will likely be dealing with its after effects for decades, according to new findings from F…
The outbreak of coronavirus infections, including COVID-19 vaccine breakthrough infections, is associated with large public gatherings, including one in Barnstable County Massachuestts, according to the Centers for Disease Control and Prevention in its…
Since the U.S. Food and Drug Administration established its accelerated approval pathway for drugs in 1992, 112 of the 253 drugs authorized have not been confirmed as clinically effective, an investigation by The BMJ has found.
The Centers for Medicare and Medicaid Services has released its projections for average basic monthly premiums for standard Medicare Part D coverage in 2022, which the agency expects will be about $33 — a 4.9% increase from the $31.47 average premium …
CMS has adopted a vaccination measure to assess whether skilled nursing facilities are taking steps to control the spread of COVID-19.
Highmark Health has announced the launch of Lumevity, a wholly-owned subsidiary that offers consulting services to other businesses to help them achieve large-scale transformation.
Lumevity is a mixture of digital solutions such as the automation of re…
Close to half of all Medicare beneficiaries, totaling around 24 million people, did not have dental coverage in 2019, and the same percentage did not have a dental visit within the past year, according to a new analysis published by the Kaiser Family F…
Major health insurer Humana logged a net income of $588 million during the second quarter, the company announced this week. And while that’s considerably less than the $1.8 billion posted a year ago at this time, when patients were deferring care, it s…
Pfizer is having ongoing discussions with regulatory agencies for a booster dose of its COVID-19 vaccine and is potentially submitting an emergency use authorization application for the additional vaccine as early as August.
